Clinical Research Trials Archive – Closed Trials

This is our archive of closed clinical trials, which means that they are no longer accepting new participants or have been concluded. Once a research facility has chosen to close the study, it is sorted into the GPS archive by indication. If you are interested in enrolling in a clinical trial, then please browse our list of active clinical studies.

Zip code

Condition


Search Radius:25 Miles
  • 5
  • 10
  • 15
  • 20
  • 25
  • 30
  • 40
  • 50
  • 100
  • 500
  • All

We've found
2,763
archived clinical trials in
Colitis

Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
University of Pittsburgh
973
mi
from
Pittsburgh, PA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
University of Pittsburgh
973
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Vanderbilt University
618
mi
from
Nashville, TN
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Vanderbilt University
618
mi
from
Nashville, TN
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Baylor College of Medicine
569
mi
from
Houston, TX
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Baylor College of Medicine
569
mi
from
Houston, TX
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Virginia Mason Medical Center
1410
mi
from
Seattle, WA
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Virginia Mason Medical Center
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
The Mayo Clinic
515
mi
from
Rochester, MN
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
The Mayo Clinic
515
mi
from
Rochester, MN
Click here to add this to my saved trials
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated:  3/3/2016
Weill-Cornell Medical College
1289
mi
from
New York, NY
Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis
A Prospective, Randomized, Double-blind, Placebo-controlled Phase II Clinical Study of Trichuris Suis Ova Treatment in Left-sided Ulcerative Colitis and Its Effects on Mucosal Immune State and Microbiota
Status: Enrolling
Updated: 3/3/2016
Weill-Cornell Medical College
1289
mi
from
New York, NY
Click here to add this to my saved trials
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study
Status: Enrolling
Updated:  3/9/2016
University of Pittsburgh
973
mi
from
Pittsburgh, PA
Anal Human Papillomavirus in Inflammatory Bowel Disease Study
Characterization of Anal Human Papillomavirus (HPV) Infection in the University of Pittsburgh Inflammatory Bowel Disease (IBD) Cohort Study
Status: Enrolling
Updated: 3/9/2016
University of Pittsburgh
973
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Fecal Microbiota Transplantation in Pediatric Patients
A Study of Fecal Microbiota Transplantation in Pediatric Patients With Relapsed Inflammatory Bowel Disease.
Status: Enrolling
Updated:  4/1/2016
Children's Hospital of Pittsburgh of UPMC
974
mi
from
Pittsburgh, PA
Fecal Microbiota Transplantation in Pediatric Patients
A Study of Fecal Microbiota Transplantation in Pediatric Patients With Relapsed Inflammatory Bowel Disease.
Status: Enrolling
Updated: 4/1/2016
Children's Hospital of Pittsburgh of UPMC
974
mi
from
Pittsburgh, PA
Click here to add this to my saved trials
Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in Children
A Phase I Study of Fecal Microbiota Transplantation (FMT) in Immunomodulator Dependent Pediatric Ulcerative Colitis (UC)
Status: Enrolling
Updated:  4/4/2016
Texas Children's Hospital
572
mi
from
Houston, TX
Fecal Microbiota Transplantation (FMT) for Treatment of Ulcerative Colitis in Children
A Phase I Study of Fecal Microbiota Transplantation (FMT) in Immunomodulator Dependent Pediatric Ulcerative Colitis (UC)
Status: Enrolling
Updated: 4/4/2016
Texas Children's Hospital
572
mi
from
Houston, TX
Click here to add this to my saved trials
Efficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic Therapy
Study of the Efficacy of Loperamide in Treating Patients for Clostridium Difficile Colitis and Diarrheal Disease of Unknown Cause Associated With Prior Antibiotic Therapy.
Status: Enrolling
Updated:  5/2/2016
VAMC
572
mi
from
Houston, TX
Efficacy of Loperamide for C. Difficile Colitis and Other Diarrheal Diseases Associated With Antibiotic Therapy
Study of the Efficacy of Loperamide in Treating Patients for Clostridium Difficile Colitis and Diarrheal Disease of Unknown Cause Associated With Prior Antibiotic Therapy.
Status: Enrolling
Updated: 5/2/2016
VAMC
572
mi
from
Houston, TX
Click here to add this to my saved trials
Evaluation of Health Costs and Resource Utilization
A Randomized Evaluation of Health Costs and Resource Utilization Comparing Testing-Based Therapy to Empiric Dose Intensification for the Management of Inflammatory Bowel Disease.
Status: Enrolling
Updated:  5/12/2016
Rocky Mountain Gastroenterology Associates
409
mi
from
Denver, CO
Evaluation of Health Costs and Resource Utilization
A Randomized Evaluation of Health Costs and Resource Utilization Comparing Testing-Based Therapy to Empiric Dose Intensification for the Management of Inflammatory Bowel Disease.
Status: Enrolling
Updated: 5/12/2016
Rocky Mountain Gastroenterology Associates
409
mi
from
Denver, CO
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
859
mi
from
Sun City, AZ
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
859
mi
from
Sun City, AZ
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1175
mi
from
Mission Hills, CA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1175
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1143
mi
from
San Diego, CA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
407
mi
from
Littleton, CO
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
407
mi
from
Littleton, CO
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1320
mi
from
Miami, FL
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1320
mi
from
Miami, FL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1310
mi
from
Miramar, FL
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1310
mi
from
Miramar, FL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1140
mi
from
Winter Park, FL
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1140
mi
from
Winter Park, FL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1026
mi
from
Savannah, GA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1026
mi
from
Savannah, GA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
610
mi
from
Chicago, IL
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
610
mi
from
Chicago, IL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
600
mi
from
Oak Lawn, IL
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
600
mi
from
Oak Lawn, IL
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
653
mi
from
Hammond, LA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
653
mi
from
Hammond, LA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
844
mi
from
Rochester Hills, MI
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
844
mi
from
Rochester Hills, MI
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
722
mi
from
Ocean Springs, MS
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
722
mi
from
Ocean Springs, MS
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
335
mi
from
Mexico, MO
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
335
mi
from
Mexico, MO
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1301
mi
from
Great Neck, NY
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1301
mi
from
Great Neck, NY
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1122
mi
from
Rochester, NY
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1122
mi
from
Rochester, NY
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
979
mi
from
Winston Salem, NC
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
979
mi
from
Winston Salem, NC
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
726
mi
from
Cincinnati, OH
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
726
mi
from
Cincinnati, OH
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1206
mi
from
Phoenixville, PA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1206
mi
from
Phoenixville, PA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
576
mi
from
Pasadena, TX
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
576
mi
from
Pasadena, TX
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
583
mi
from
San Antonio, TX
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
583
mi
from
San Antonio, TX
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
575
mi
from
Sugar Land, TX
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
575
mi
from
Sugar Land, TX
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1053
mi
from
Charlottesville, VA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1053
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1410
mi
from
Seattle, WA
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1410
mi
from
Seattle, WA
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
630
mi
from
Wauwatosa, WI
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
630
mi
from
Wauwatosa, WI
Click here to add this to my saved trials
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
5123
mi
from
Innsbruck,
Efficacy and Safety of SAR339658 in Patients With Moderate to Severe Ulcerative Colitis
A Randomized, Double-Blind, Placebo-Controlled, Multicenter Study Evaluating Efficacy and Safety of SAR339658 in Patients With Active Moderate to Severe Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
5123
mi
from
Innsbruck,
Click here to add this to my saved trials
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1175
mi
from
Mission Hills, CA
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1175
mi
from
Mission Hills, CA
Click here to add this to my saved trials
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1310
mi
from
Miramar, FL
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1310
mi
from
Miramar, FL
Click here to add this to my saved trials
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
335
mi
from
Mexico, MO
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
335
mi
from
Mexico, MO
Click here to add this to my saved trials
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
583
mi
from
San Antonio, TX
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
583
mi
from
San Antonio, TX
Click here to add this to my saved trials
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated:  7/12/2016
Clinical Research Facility
1140
mi
from
Winter Park, FL
Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
A Multicenter Single-Arm Open Label Extension Study Evaluating The Long Term Safety And Tolerability Of SAR339658 In Patients With Ulcerative Colitis (UC)
Status: Enrolling
Updated: 7/12/2016
Clinical Research Facility
1140
mi
from
Winter Park, FL
Click here to add this to my saved trials
Single-dose Linaclotide for Capsule Endoscopy Preparation
Single-dose Linaclotide for Capsule Endoscopy Preparation
Status: Enrolling
Updated:  7/13/2016
University of Virginia Health System
1049
mi
from
Charlottesville, VA
Single-dose Linaclotide for Capsule Endoscopy Preparation
Single-dose Linaclotide for Capsule Endoscopy Preparation
Status: Enrolling
Updated: 7/13/2016
University of Virginia Health System
1049
mi
from
Charlottesville, VA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
808
mi
from
Ann Arbor, MI
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
808
mi
from
Ann Arbor, MI
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
515
mi
from
Rochester, MN
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
515
mi
from
Rochester, MN
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1143
mi
from
San Diego, CA
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1143
mi
from
San Diego, CA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1047
mi
from
Gainesville, FL
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1047
mi
from
Gainesville, FL
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
801
mi
from
Atlanta, GA
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
801
mi
from
Atlanta, GA
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1123
mi
from
Chevy Chase, MD
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1123
mi
from
Chevy Chase, MD
Click here to add this to my saved trials
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated:  8/1/2016
Clinical Research Facility
1301
mi
from
Great Neck, NY
Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Phase II Randomized Double-Blind Placebo-Controlled Study to Evaluate the Efficacy and Safety of rhuMAb Beta7 in Patients With Moderate to Severe Ulcerative Colitis
Status: Enrolling
Updated: 8/1/2016
Clinical Research Facility
1301
mi
from
Great Neck, NY
Click here to add this to my saved trials